• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP PSA; PSA IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP PSA; PSA IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/07/2014
Event Type  malfunction  
Event Description
A false low advia centaur xp psa result was obtained on a patient sample.The low result was considered discordant when compared to the patient's previous result from a month ago.Repeat testing was performed with 1:2 dilution and 1:100 dilution.The results were higher.A corrected report was sent to the physician.The patient sample was tested again neat and the result was low.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the discordant advia centaur xp psa result.
 
Manufacturer Narrative
The cause for the discordant advia centaur xp psa result may be due to the hook effect.The quality control was acceptable.The instrument is performing within specification.No further evaluation of the device is required.The ifu states in the high-dose hook effect section: "patient samples with high total psa levels can cause a paradoxical decrease in the rlus (high-dose hook effect).In this assay, patient samples with total psa levels as high as 10,000 ng/ml (10,000 ug/l) will assay greater than 100 ng/ml (100 ug/l)." the ifu states in the limitations section: "note: do not interpret levels of psa as absolute evidence of the presence or the absence of malignant disease.Before treatment, patients with confirmed prostate carcinoma frequently have levels of psa within the range observed in healthy individuals.Elevated levels of psa can be observed in patients with nonmalignant diseases.Measurements of psa should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP PSA
Type of Device
PSA IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
walpole MA 02032
Manufacturer Contact
eiman sulieman
333 coney street
east walpole, MA 02032
5086604603
MDR Report Key3655829
MDR Text Key4281744
Report Number1219913-2014-00055
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P950021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Health Professional
Remedial Action Inspection
Type of Report Initial
Report Date 02/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/06/2014
Device Model NumberN/A
Device Catalogue Number06574155
Device Lot Number249
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/07/2014
Initial Date FDA Received03/03/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-